Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about PDGFRB: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
PDGFRB is a gene implicated in neurodegeneration research. Key relationships include: activates, associated with, biomarker for. Associated with ALS, Aging, Als. Connected to 299 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | PDGFRB |
| Full Name | Platelet Derived Growth Factor Receptor Beta |
| Chromosome | 5q32 |
| Protein Type | Kinase |
| Target Class | Kinase |
| Function | PDGFRB encodes the beta chain of the platelet-derived growth factor receptor, a receptor tyrosine kinase that binds PDGF-BB and PDGF-AB. |
| Mechanism of Action | Small molecule inhibitor of receptor tyrosine kinase activity |
| Druggability | Medium (0.50) |
| Clinical Stage | Approved |
| Pathways | PI3K, MAPK |
| UniProt ID | E5RII0 |
| Ensembl ID | ENSG00000113721 |
| OMIM | 173410 |
| GeneCards | PDGFRB |
| Human Protein Atlas | PDGFRB |
| Associated Diseases | Aging, Als, Alzheimers_disease, Basal Ganglia Calcifications, Cardiac |
| Known Drugs/Compounds | dasatinib, tyrosine_kinase_inhibitor |
| Interactions | ABCB1, ABL1, ABL2, AKT, AND, ANG |
| SciDEX Target | View Target Profile (8 clinical trials) |
| SciDEX Hypotheses | Pericyte Contractility Reset via Selective PDGFR-β Pericyte-First Sequential Biomarker Cascade — Solu Vascular mural cell degeneration precedes and exac |
| KG Connections | 578 knowledge graph edges |
| Databases | GeneCardsNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
PDGFRB["PDGFRB"] -->|"associated"| neurodegeneration["neurodegeneration"]
PDGFRB["PDGFRB"] -->|"interacts"| ANGPT1["ANGPT1"]
PDGFRB["PDGFRB"] -->|"co discussed"| TGFB1["TGFB1"]
ANGPT1_1["ANGPT1"] -->|"interacts"| PDGFRB["PDGFRB"]
AQP1["AQP1"] -->|"co discussed"| PDGFRB["PDGFRB"]
KCNK2["KCNK2"] -->|"co discussed"| PDGFRB["PDGFRB"]
GJA1["GJA1"] -->|"co discussed"| PDGFRB["PDGFRB"]
style PDGFRB fill:#4a1a6b,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Primary Familial Brain Calcification | causes | disease | 0.95 |
| Primary Familial Brain Calcification | associated_with | disease | 0.95 |
| Basal Ganglia Calcifications | causes | disease | 0.93 |
| Fahr's Disease | risk_factor_for | disease | 0.90 |
| Cerebrovascular Integrity | biomarker_for | process | 0.85 |
| neurovascular unit | modulates | cell_type | 0.80 |
| pericyte_function | maintains | pathway | 0.80 |
| hepatic_stellate_cells | activates | cell_type | 0.72 |
| liver_fibrosis | activates | disease | 0.72 |
| myofibroblasts | expressed_in | cell_type | 0.72 |
| Ph_like_ALL | associated_with | disease | 0.72 |
| oxidative stress response | participates_in | pathway | 0.70 |
| Inflammation | associated_with | disease | 0.65 |
| Als | biomarker_for | disease | 0.65 |
| ALS | activates | disease | 0.65 |
| Neurodegeneration | biomarker_for | disease | 0.65 |
| Aging | associated_with | disease | 0.65 |
| Ms | associated_with | disease | 0.65 |
| Parkinson | associated_with | disease | 0.65 |
| Als | regulates | disease | 0.65 |
| Leukemia | activates | disease | 0.65 |
| Ms | regulates | disease | 0.65 |
| Ms | interacts_with | disease | 0.65 |
| Cardiac | associated_with | disease | 0.65 |
| Fibrosis | activates | disease | 0.65 |
| Ms | expressed_in | disease | 0.65 |
| Tumor | expressed_in | disease | 0.65 |
| Senescence | therapeutic_target | disease | 0.65 |
| Leukemia | therapeutic_target | disease | 0.65 |
| Ms | inhibits | disease | 0.65 |
| Fibrosis | therapeutic_target | disease | 0.65 |
| Neuroinflammation | associated_with | disease | 0.65 |
| Alzheimer | biomarker_for | disease | 0.65 |
| Cardiomyopathy | associated_with | disease | 0.65 |
| Aging | activates | disease | 0.65 |
| Inflammation | expressed_in | disease | 0.65 |
| Als | associated_with | disease | 0.65 |
| Senescence | activates | disease | 0.65 |
| Tumor | regulates | disease | 0.65 |
| Carcinoma | activates | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Alzheimer | therapeutic_target | disease | 0.65 |
| Cardiovascular | activates | disease | 0.65 |
| Inflammation | activates | disease | 0.65 |
| Arthritis | activates | disease | 0.65 |
| Tumor | activates | disease | 0.65 |
| ALS | biomarker_for | disease | 0.65 |
| Als | activates | disease | 0.65 |
| ALS | regulates | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| h-73e4340b | targets | hypothesis | 0.90 |
| h-35f04e1b | targets | hypothesis | 0.90 |
| h_seaad_005 | targets_gene | hypothesis | 0.90 |
| STING | upregulates | protein | 0.85 |
| PDGF_BB | activates | protein | 0.72 |
| PDGFD | interacts_with | protein | 0.72 |
| tyrosine_kinase_inhibitor | inhibits | drug | 0.72 |
| PDGF | activates | protein | 0.72 |
| dasatinib | inhibits | drug | 0.72 |
| CRLF2 | activates | gene | 0.70 |
| MFSD2A | inhibits | gene | 0.65 |
| CSF1R | activates | gene | 0.60 |
| MYC | inhibits | gene | 0.60 |
| SRC | inhibits | gene | 0.60 |
| TAU | associated_with | gene | 0.60 |
| APOE Ε4 | biomarker_for | gene | 0.60 |
| INSR | activates | gene | 0.60 |
| VEGFB | activates | gene | 0.60 |
| STING | activates | gene | 0.60 |
| PDGFB | associated_with | gene | 0.60 |
| AND | interacts_with | gene | 0.60 |
| FLT3 | contributes_to | gene | 0.60 |
| CRLF2 | inhibits | gene | 0.60 |
| JAK | inhibits | gene | 0.60 |
| APOD | activates | gene | 0.60 |
| GENES | inhibits | gene | 0.60 |
| COL1A1 | activates | gene | 0.60 |
| INFLAMMATION | activates | gene | 0.60 |
| THBS2 | regulates | gene | 0.60 |
| ALZHEIMER'S DISEASE | therapeutic_target | gene | 0.60 |
| INFLAMMATION | expressed_in | gene | 0.60 |
| CMPK2 | associated_with | gene | 0.60 |
| AND | regulates | gene | 0.60 |
| PDGF | expressed_in | gene | 0.60 |
| RNA | expressed_in | gene | 0.60 |
| AND | expressed_in | gene | 0.60 |
| AND | inhibits | gene | 0.60 |
| PDGF | inhibits | gene | 0.60 |
| NINJ2 | activates | gene | 0.60 |
| PDGF | interacts_with | gene | 0.60 |
| SQSTM1 | biomarker_for | gene | 0.60 |
| NEFL | biomarker_for | gene | 0.60 |
| CHI3L1 | associated_with | gene | 0.60 |
| BDNF | biomarker_for | gene | 0.60 |
| ANGPT1 | associated_with | gene | 0.60 |
| CHI3L1 | interacts_with | gene | 0.60 |
| CHIT1 | interacts_with | gene | 0.60 |
| NPTX1 | interacts_with | gene | 0.60 |
| PDGFRA | implicated_in | gene | 0.60 |
| EPOR | activates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Pericyte Contractility Reset via Selective PDGFR-β Agonism | 0.684 | neurodegeneration | Perivascular spaces and glymphatic clear |
| Pericyte-First Sequential Biomarker Cascade — Soluble PDGFR- | 0.662 | - | Blood-brain barrier permeability changes |
| Vascular mural cell degeneration precedes and exacerbates pa | 0.637 | Alzheimer's disease | SEA-AD Single-Cell Analysis: Cell-Type V |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-03 | 18 hypotheses Top: 0.847
neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.841
neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.756
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| Irisin effects on angiogenesis in human endothelial cells | exploratory | bone fracture | 0.900 | 0.00 | human umbilical vein endotheli | proposed | N/A |
| Proposed experiment from debate on Perivascular spaces and glymphatic | falsification | Neurodegeneration | 0.400 | 0.50 | cell_line | proposed | $100,000 |
| Vascular Contribution to Alzheimer's Disease — Beyond Amyloid | validation | Alzheimer's Disease | 0.400 | 0.50 | human | proposed | $2,280,000 |
| Vascular Contributions to Alzheimer Disease and Mixed Pathology | clinical | Alzheimer's Disease | 0.400 | 0.50 | human | proposed | $5,460,000 |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Targeting ECM-producing cells with CAR-T therapy alleviates fibrosis in chronic [PMID:40848726] | Zhao S, Li R, Xia Y, Wang X, Liu Z, Chu | Cell Stem Cell | 2025 | 1 |
| Neurovascular unit, neuroinflammation and neurodegeneration markers in brain dis [PMID:39526043] | Kempuraj D, Dourvetakis KD, Cohen J, Val | Front Cell Neurosci | 2024 | 1 |
| The Genetics of Primary Familial Brain Calcification: A Literature Review. [PMID:37446066] | Chen SY, Ho CJ, Lu YT, Lin CH, Lan MY, T | Int J Mol Sci | 2023 | 1 |
| Interplay of Low-Density Lipoprotein Receptors, LRPs, and Lipoproteins in Pulmon [PMID:35257044] | Calvier L, Herz J, Hansmann G | JACC Basic Transl Sci | 2022 | 1 |
| Decoding myofibroblast origins in human kidney fibrosis. [PMID:33176333] | Kuppe C, Ibrahim MM, Kranz J, Zhang X, Z | Nature | 2021 | 1 |
| APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline. [PMID:32376954] | Montagne A, Nation DA, Sagare AP, Barisa | Nature | 2020 | 1 |
| Pathophysiology of Primary Familial Brain Calcification. [PMID:41212990] | Keller A | Annual review of physiology | 2026 | 0 |
| A FZD4/LRP5 agonist restores pericyte coverage and vascular integrity by increas [PMID:41890033] | Levey J, Howe M, Douglas K, Odame E, Raj | bioRxiv : the preprint server | 2026 | 0 |
| Therapeutic effects of the n-butanol extract of Potentilla freyniana Bornm. in h [PMID:40902811] | Wang Y, Zhang Z, Cao L, Huang S, Huang X | J Ethnopharmacol | 2026 | 0 |
| Based on network pharmacology and experiments to investigate the inhibitory effe [PMID:41308710] | Yang X, Xiao JH, Li X, Liu RM, Yuan Q | J Ethnopharmacol | 2026 | 0 |
| Novel insights into meningioma brain invasion with spatial transcriptomic profil [PMID:41486296] | Maier AD, Laurentiussen CO, Michaelsen S | Acta Neuropathol Commun | 2026 | 0 |
| Brain vascular stability relies on PAK2-cilia-PDGF-BB-HSPGs on basolateral side [PMID:41490797] | Prabhudesai S, Thirugnanam K, Song X, Ya | Life Sci Alliance | 2026 | 0 |
| Plasma platelet-derived growth factor receptor-β decrease correlates with blood- [PMID:41530860] | Li J, Li A, Ye C, Zhang L, Jiang M et al | Mol Neurodegener | 2026 | 0 |
| FOXF2 regulates pericyte-endothelial signaling required for vascular homeostasis [PMID:41680210] | Sun F, Zhao Y, Do J, Cheng P, Li E et al | Nat Commun | 2026 | 0 |
| Nano-Enabled Fluorescence Switching: A Novel Strategy for PDGFRβ Detection and T [PMID:41884335] | Fu X, Fan J, Chen H, Zheng Y, Liu Y, Zha | Research (Washington, D.C.) | 2026 | 0 |
| Loss of Pericyte Exacerbates Alzheimer's Disease-Associated Retinal Pathology. [PMID:41814129] | Hai-Chao C, Fu-Lin G, Jia-Xin C, Yi-Shu | Clinical & experimental ophtha | 2026 | 0 |
| Central nervous system pericytes express soluble ST2 in inflammation and injury. [PMID:41857656] | Jansson D, Highet B, Li S, Stevenson TJ, | Molecular brain | 2026 | 0 |
| Astrocyte-Glioblastoma Stem Cell Interactions via Extracellular Vesicles Contrib [PMID:41712235] | Shirai Y, Tsuda M, Wang L, Oda Y, Sugizn | Pathology international | 2026 | 0 |
| The role of endothelial cell-pericyte interactions in vascularization and diseas [PMID:38246244] | Li G, Gao J, Ding P, Gao Y | Journal of advanced research | 2025 | 0 |
| Pericytes in Brain Homeostasis: Developmental Roles and Adult Functions. [PMID:41351407] | Drozd U, Vechkapova S, Lanshakov D | Frontiers in bioscience (Landm | 2025 | 0 |
Multi-agent debates referencing this entity
closed · Rounds: 4 · Score: 0.95 · 2026-04-06
closed · Rounds: 4 · Score: 0.95 · 2026-04-06
closed · Rounds: 4 · Score: 0.90 · 2026-04-03
Hypotheses and analyses mentioning PDGFRB in their description or question text
No additional research found